Interventional Cardiovascular Specialist

  • ​​​​​Entrepreneur who developed both the concept of the guide sheath and thrombi-embolectomy catheter in use today
  • Previously served as System Medical Chief for Vascular Disease at OhioHealth (12 institutions from tertiary care to community hospitals)
    • Coordinated cardiovascular care across the system
    • Integrated care delivery and quality outcomes for multiple specialties including VS, IR, IC, VM.
    • System Supply Chain Committee member
  • Helped develop the field of endovascular care and performed many firsts including the first pedal access for limb salvage
  • Associate Director for the OhioHealth Research Foundation that has participated in hundreds of trials
  • Research primary investigator for both national and international trials
  • Important insight into product development and adoption by KOLs and the community physician
  • Founder and organizer of the most influential vascular medical education symposia in the world
  • Published over 100 peer-reviewed publications

David H. Deaton, MD

Vascular Surgeon

  • ​​​​​Leading role in 5 start-up companies with successful exits: 
    • EVT Ancure - 1st approved EVAR device in US: sold to Guidant
    • Aptus HeliFx - 1st approved catheter based aortic suture device; sold to Medtronic.
    • Intact Tack - 1st approved BTK vascular implant; sold to Philips
    • Devoro WOLF thrombectomy device - sold to Boston Scientific
    • LimFlow deep vein arterialization device & procedure - 1st approved DVA system/device in the world; sold to Inari
  • Inventor on multiple patents in aortic, lower extremity disease, thrombectomy, deep vein arterialization
  • CMO experience for start-ups (Aptus, Devoro), public (Endologix) and CRO (Syntactx)
  • 3 years of dedicated NIH-sponsored laboratory research in transplantation, immunobiology, and microsurgery
  • Provided primary testimony for FDA panel review of 1st approved EVAR device; multiple FDA meetings/interactions over 25 years for clients and FDA educational activities
  • Provided primary testimony for ICD codes for all endovascular aorto-iliac (1999) and endovascular bypass procedures (2020); multiple CMS visits over 25 years for reimbursement of new procedures/devices
  • Over 30 years of advisory positions for more than 25 companies
  • Former Chief of Vascular Surgery, Georgetown University
  • Academic appointments at University Pennsylvania, UCLA, University of Maryland, East Carolina University, Georgetown University
  • Invited speaker for > 180 presentations throughout N. America, Europe, Asia/Pacific
  • Primary investigator on multiple Phase I and II studies for endovascular treatment of aortic, carotid, lower extremity disease
  •  Invited expert on CNN, CNN Headline News, CNN International, CNN Situation Room, CNN Erin Burnett OutFront


Vascular Medicine Specialist

  • Full Professor of Medicine, Harvard Medical School
  • Former President and CEO of largest community hospital within Partners Healthcare
  • Founded and managed the largest vascular device imaging core lab in the world...over 300 seminal multicenter clinical trials in 66 countries around the world. Integrated into Massachusetts General Hospital
  • Graduate, Harvard Business School
  • First recipient of the Paul and Phyllis Fireman Endowed Chair in Vascular Medicine at Massachusetts General Hospital
  • Founder and organizer of the most influential vascular medical education symposia in the world
  • Consulted to FDA, CMS and many small/medium/large medical device and pharmaceutical companies
  • Chief Medical Officer of large multinational medical device manufacturer
  • Published over 300 peer-reviewed publications

Peter A. Schneider, MD

Vascular Surgeon, Educator, and Medical Device Developer

  • Pioneer in minimally invasive vascular surgery with nearly three decades in the healthcare and medical device space including CMO responsibilities, clinical trials planning and execution  
  • Co-Founder of Intact Vascular and Cagent Vascular and holder of numerous patents
  • Founding Member and Chief: Division of Vascular Surgery, Kaiser Permanente, Hawaii (1994-2018)
  • National or Site Principal Investigator for numerous clinical trials 
  • Distinguished Fellow in the Society for Vascular Surgery
  • Past President for the Western Vascular Society and Vascular and Interventional Advances (VIVA)
  • Invited to numerous national and international visiting professorships and performed revascularization procedures in more than a dozen countries
  • Authored "Endovascular Skills," 4th edition published in 2019
  • Professor of Surgery: Division of Vascular & Endovascular Surgery, University of California San Francisco
  • Doctor of Medicine from the Johns Hopkins School of Medicine
  • Vascular Surgery Training: Completed at the University of California San Francisco


Healthcare Attorney

  • Co-founded an innovative outsourced general counsel legal practice focused on early stage and operational development
  • Co-founded first organization dedicated to assisting physicians in developing, managing, and complying with complex regulatory requirements relating to industry relationships
  • Startup attorney experienced with formation, hiring customer relationships, and board and investor management
  • Deep knowledge of funding and acquisition process from term sheet through closing
  • Spent career advising and working with company founders to help make key operational decisions, avoid common errors, and navigate issues arising for early-stage companies
  • Experienced with licensing of intellectual property out of research institutions
  • Entrepreneurial attorney with reputation across the medical device world as highly credible and ethical

Craig McChesney, Esq

Medical Entrepreneur and Attorney

  • Founder of Endovascular Today and Cardiac Interventions Today, the two leading global publications in the fields of endovascular therapies and interventional cardiology. Served as Publisher of both publications for over 20 years
  • Co-founder of Bryn Mawr Communications, a multifaceted medical media company with media products across a diverse portfolio of fields including neurology, dermatology, and cardiovascular
  • Twenty-two years of experience working with numerous marketing professionals at over 100 endovascular and interventional cardiology companies.
  • Assisted medical device companies formulate and execute their marketing strategies, including:
    • Sponsored editorial content creation
    • Print and digital ad design and placement
    • Video production
  • Extensive work with KOLs across both endovascular therapies and interventional cardiology to curate the most pertinent and timely editorial content
  • Organized, facilitated, and moderated physician roundtables and advisory boards in both the US and Europe. 
  • Twelve years as a practicing attorney, both as general counsel and corporate litigator